# Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

> **NCT03405363** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 65406 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03405363
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2020-02-03
- **Final completion:** 2020-02-03
- **Target enrollment:** 65406 (ACTUAL)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405363, "Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03405363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*